Ampio Announces Publication of Ampion(TM) Treatment of Severe Osteoarthritis of the Knee as a Feature Article in Orthopedics Peer-Reviewed Journal

ENGLEWOOD, Colo., Nov. 22, 2017 -- (Healthcare Sales & Marketing Network) -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that a manuscript entitled: "LMWF-5A for the Treatment of Severe Osteoarthritis of the Knee: Integrated Analysis... Biopharmaceuticals, Orthopaedic Ampio Pharmaceuticals, osteoarthritis, Ampion
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news